Laboratory models of sepsis and septic shock

Journal of Surgical Research

Volumn 49, Issue 2, 1990, Pages 186-196

  Fink, Mitchell P ^a   Heard, Stephen O ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE;

ANIMAL MODEL; ENDOTOXICOSIS; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; RAT; REVIEW; SEPSIS; SHOCK;

ANIMAL; BACTERIA; CECUM; DISEASE MODELS, ANIMAL; ENDOTOXINS; INFECTION; INJECTIONS; LIGATION; LIPOPOLYSACCHARIDES; PERITONITIS; SHOCK, SEPTIC; SUPPORT, U.S. GOV'T, P.H.S.; TERMINOLOGY;

EID: 0025354406     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/0022-4804(90)90260-9     Document Type: Article

References (115)

1. Sepsis and septic shock—A review of laboratory models and a proposal
2. Septic shock: Hemodynamics and pathogenesis
3. Clinical predictors of the adult respiratory distress syndrome
4. Physiology and metabolism in isolated viral septicemia: Further evidence of an host-dependent response
5. Cardiorespiratory patterns in viral septicemia
6. The systemic septic response Does the organism matter?
7. The microbiology of multiple organ failure: The proximal gastrointestinal tract as an occult reservoir of pathogens
8. The surgical intensive care unit: Current concepts in infection
9. Adult respiratory distress syndrome: A live E. coli septic primate model
10. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates
11. Skeletal microcirculatory responses to hyperdynamic Escherichia coli sepsis in unanesthetized rats
12. Prostaglandins maintain renal microvascular blood flow during hyperdynamic bacteremia
13. Effect of endotoxin and trauma on survival after cecal ligation and puncture in mice
14. Clarifications of the role of endotoxin in intra-abdominal and systemic sepsis
15. The role of C5 in septic lung injury
16. The association of Escherichia coli virulence and pulmonary microvascular damage
17. Increased sheep lung vascular permeability caused by Pseudomonas bacteremia
18. The pulmonary and systemic response to recurrent endotoxemia in the adult sheep
19. Effect of endotoxin on diaphragm lymph contamination in unanesthetized sheep
20. Ibuprofen reduces the progression of permeability edema in an animal model of hyperdynamic sepsis
21. Increased lymphatic elimination of interstitial hyaluronan during E coli sepsis in sheep
22. Removal of abdominal sources of caudal mediastinal node lymph in anesthetized sheep
23. Preparation of chronic lung lymph fistulas in sheep
24. A model of ovine endotoxemia characterized by an increased cardiac output
25. Cardiopulmonary responses to continuous administration of endotoxin
26. The pig model for biomedical research
27. Bacterial endotoxin: Chemical structure, biological activity and role in septicemia
28. Sequential cardiorespiratory patterns in septic shock
29. Hemodynamic determinants of mortality in human septic shock
30. Profound but reversible myocardial depression in patients with septic shock
31. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis
32. Causes of mortality in patients with the adult respiratory distress syndrome
33. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia
34. A comparison of Escherichia coli endotoxin single bolus injection with low-dose endotoxin infusion on pulmonary and systemic vascular changes
35. Effects of endotoxin on regional blood flow in the unanesthetized guinea pig
36. Comparison of canine responses to Escherichia coli organisms and endotoxin
37. Distribution of respiratory muscle and organ blood flow during endotoxic shock in dogs
38. Nalaxone alters organ perfusion during endotoxin shock in conscious rats
39. The effects of endotoxin on distribution of cardiac output in unanesthetized rabbits
40. Hypoglycemic depression of RES function
41. Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock
42. Effect of injury and infection on visceral metabolism and circulation
43. Glucose and lactate metabolism in experimental septic shock
44. Lack of clinical usefulness of the limulus test and the diagnosis of endotoxemia
45. Limitations of the usefulness of the limulus assay for endotoxin
46. Salmonellosis in mice infected with Mycobacterium tuberculosis BCG. I. Role of endotoxin in infection
47. The role of endotoxin during typhoid fever and tularemia in man. IV. The integrity of the endotoxin tolerance mechanism during infection
48. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice
49. Endotoxin sensitivity of inbred mouth strains
50. Role of endotoxemia in cardiovascular dysfunction and mortality: Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock
51. Endotoxemia in critically ill patients
52. Endotoxaemia: An early predictor of septicaemia in febrile patients
53. Inhibition of cyclo-oxygenase attenuates the metabolic response to endotoxin in humans
54. Endotoxin (E) administration produces abnormal cardiovascular (CV) responses in normal humans
55. Intravenous endotoxin (E) to normal humans causes gas exchange abnormalities and increased alveolar epithelial permeability
56. Protection of mice against lethal endotoxemia by a lipid A precursor
57. Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits
58. E. coli endotoxin produces hyperdynamic hemodynamics in the rat
59. Mesenteric vascular responses to endotoxin in the monkey and dog
60. Route of endotoxin delivery: Effects on canine mesenteric hemodynamics
61. Effect of vasopressors on organ blood flow during endotoxin shock in pigs
62. Coronary circulation in human septic shock
63. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock
64. Effect of lipopolysaccharide on intestinal intramucosal hydrogen ion concentration in pigs: Evidence of gut ischemia in a normodynamic model of septic shock
65. Complement depletion with Naje haje cobra venom factor limits prostaglandin release and improves visceral perfusion in porcine endotoxic shock
66. 2 metabolism in endotoxic pigs: Effect of ibuprofen and meclofenamate
67. Cardiovascular performance with E coli challenges in a canine model of human sepsis
68. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock
69. Myocardial dysfunction in a nonlethal, nonshock model of chronic endotoxemia
70. Canine left ventricular performance during LD50 endotoxemia
71. Left ventricular function during chronic endotoxemia in a swine
72. Comparison of effects of dextran-70 and Ringer's acetate on pulmonary function, hemodynamics, and survival in experimental septic shock
73. Hemodynamic effects of continuous norepinephrine infusion in dogs with and without hyperkinetic endotoxic shock
74. Effects of slow intravenous endotoxin infusion on hemodynamics and survival in dogs
75. Effects of continuous intravenous infusion of Escherichia coli endotoxin in swine
76. Continuous infusion of endotoxin from an osmotic pump in the conscious-unrestrained rat: A unique model of chronic endotoxemia
77. Regional blood flow during continuous low-dose endotoxin infusion
78. Induction of hypermetabolism in guinea pigs by endotoxin infused through the portal vein
79. Systemic and regional hemodynamic changes after intraperitoneal endotoxin in rabbits: Development of a new model of the clinical syndrome of hyperdynamic sepsis
80. Cardiopulmonary response of the rat to gram-negative bacteremia
81. The pathophysiology of septic shock: Changes in hemodynamics in rats following live E. coli injection
82. Survival of primates in lethal septic shock following delayed treatment with steroids
83. Evaluation of naloxone therapy for Escherichia coli sepsis in the baboon
84. 100Escherichia coli
85. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
86. The effects of high-dose corticosteroids in patients with septic shock: A prospective, controlled study
87. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis
88. Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey
89. 2 excretion in a non-human primate model of septic shock
90. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
91. Bacteremia: Host-specific lung clearance and pulmonary failure
92. Pulmonary clearance of blood-borne bacteria
93. Comparison of live bacteria infusions in a porcine model of acute respiratory failure
94. 1 in a septic porcine model of adult respiratory distress syndrome
95. Indomethacin improvement of septic acute respiratory failure in a porcine model
96. Successful use of an anti-platelet-activating factor agent in the porcine Pseudomonas ARDS model
97. Effects of ibuprofen on a pig Pseudomonas ARDS model
98. Successful treatment of adult respiratory distress syndrome by histamine and prostaglandin blockade in a porcine Pseudomonas model
99. A conscious septic dog model with hemodynamic and metabolic responses similar to responses of humans
100. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis
101. Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis
102. Hepatic and systemic metabolic response to aerobic and anaerobic intra-abdominal abscesses in a highly reproducible chronic rat model
103. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver
104. A new model for studying nutrition in peritonitis: The adverse effect of overfeeding
105. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model
106. Renal and cardiovascular response to nonhypotensive sepsis in a large animal model with peritonitis
107. Peripheral lymph flow in sheep with bacterial peritonitis: Evidence for increased peripheral microvascular permeability accompanying systemic sepsis
108. Association between renal and sympathetic responses to nonhypotensive systemic sepsis
109. Sustained hypermetabolic sepsis in rats: Characterization of the model
110. Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis
111. The increase of circulatory requirements in the presence of inflammation
112. Mechanisms for the high circulatory requirements in sepsis and septic shock
113. Hemodynamic responses to sepsis: Hypodynamic vs. hyperdynamic states
114. Hyper- and hypodynamic models of sepsis in guinea pigs
115. Chronic hyperdynamic sepsis in the rat. I. Characterization of the animal model